Mats Uno Olsson
Directeur/Membre du Conseil chez RespiVert Ltd.
Provenance du réseau au premier degré de Mats Uno Olsson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
RespiVert Ltd.
 RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom.
2
| Subsidiary | Medical Distributors | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mats Uno Olsson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Trinity College, Cambridge | College/University | Doctorate Degree | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Johnson & Johnson Innovation Ltd.
 Johnson & Johnson Innovation Ltd. Investment ManagersFinance Johnson & Johnson Innovation Ltd is a private equity subsidiary of Johnson & Johnson Innovation - JJDC, Inc. founded in 2000. The firm is headquartered in Buckinghamshire, United Kingdom. | Investment Managers | Director/Board Member | |
XO1 Ltd.
 XO1 Ltd. Medical/Nursing ServicesHealth Services XO1 Ltd. develops a novel anticoagulant drug. The firm operates as a biopharmaceutical company. The company was founded by David J. Grainger on February 28, 2013 and is headquartered in High Wycombe, the United Kingdom. | Medical/Nursing Services | Director/Board Member |
Statistiques
Internationale
| Royaume-Uni | 5 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
| Finance | 2 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Nerida Scott | 6 |
| Ian Keith Anderson | 1 |
- Bourse
- Insiders
- Mats Uno Olsson
- Connexions Sociétés
